BOSTON, Jan. 8 -- Clinical and research developments in neurology in 2006 seemed to be as much about prevention as treatment.
Among the highlights were the return to the market of Tysabri (natalizumab) for multiple sclerosis, a treatment for Parkinson's dementia, the ongoing struggles to understand the causes and treatment of autism spectrum disorders, and new evidence about the influence of diet in preventing cognitive decline.
The following summary reviews some of the major events of the year in neurologyy. For fuller accounts, links to the individual articles published in MedPage Today have been provided.
ALZHEIMER'S DISEASE
